Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines

Table 1

Summary of demographics.

Variable	Subjects
	Duration of follow-up (year)
Age (year)
Gender
Male	535 (47.51%)
Female	591 (52.49%)
Hemodialysis vintage (year)
Etiology of renal failure
Glomerulonephritis	174 (15.45%)
Diabetes mellitus	343 (30.46%)
Others	609 (54.09%)
EPO use
Yes	802 (90.62%)
No	83 (9.38%)
Missing	241
Vitamin D analogs use
Yes	237 (21.68%)
No	856 (78.32%)
Missing	33
Antihypertensive agent use
Yes	382 (34.98%)
No	710 (65.02%)
Missing	34
Iron use
Yes	103 (9.43%)
No	989 (90.57%)
Missing	34
Parathyroidectomy
Yes	188 (17.12%)
No	910 (82.88%)
Missing	28
All-cause mortality
Yes	240 (21.31%)
Cardiopulmonary system	72 (6.39%)
Central nervous system	22 (1.95%)
Infection	52 (4.62%)
Gastrointestinal hepatobiliary system	28 (2.49%)
Malignant tumor	26 (2.31%)
Other	40 (3.55%)
No	886 (78.69%)
Cardiovascular mortality
Yes	48 (4.26%)
No	1078 (95.74%)